Molecular Biology of Cancer Flashcards

1
Q

Cancer

A

Disease characterized by loss of regulation of the cell cycle, normal checkpoints are bypassed, allowing defective DNA replication and cell division, greater frequency of aneuploidy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Causes of cancer

A

Mutations lead to uncontrolled proliferation of cells, occur as a result of ionizing and UV radiation, chemicals, spontaneous errors during replication

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Normal detection of mutations

A

Cell has mechanisms for detecting mutations and halting genetic processes until corrections are made, if the mutation is severe, the cell undergoes apoptosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Uncontrollable growth

A

Mutated cells proliferate and develop further mutations, tumor becomes most dangerous when it gains the ability to invade surrounding tissues and proliferate in distant sites (metastasis)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Defects in DNA repair

A

BRCA-1,2, causes breast, ovarian, and prostate cancer, repair by homologous recombination

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Differences between normal cells and malignant cells

A

Infinite proliferative capacity, anchorage independent, resistant to growth inhibition, resistant to apoptosis, show signs of de-differentiation, can be metastatic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Oncogenes

A

Result from gain-of-function mutations of growth-promoting genes, corresponding normal gene is a proto-oncogene

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Tumor suppressor genes

A

Normal genes that encode growth-inhibiting products that become inactivated in cancer cells (loss-of-function), inhibition of growth-inhibiting activities results in unregulated cell growth

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Varmus and Bishop

A

Hypothesized that cancer is caused by mutations in cellular genes (not viruses), many v-onc have been isolated from retroviruses, cellular proto-oncogenes (c-onc) have been found

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Classes of cellular proto-oncogenes (c-onc)

A

Cellular growth factors, hormone and growth factor receptors, signal transduction proteins, GTP-binding proteins, nonreceptor protein kinases, transcription factors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Cell cycle

A

Activated by growth factors, hormone messengers, work through cyclins and cyclin-dependent kinases (CDKs), regulated by phosphorylation and cyclin-dependent kinase inhibitors (CKIs)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Conversion of proto-oncogene to oncogenes

A

Radiation or chemical mutagen, gene rearrangement- places proto-oncogene under control of strong transcriptional activator and fuses with with another protein, gene amplification

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Mitogen activated protein kinase pathway

A

MAP kinase pathway activates transcription of myc and fos, phosphorylates AP-1 (fos and jun)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Ras

A

Monomeric G-protein in the cascade mediating cell growth/mitosis control by growth factors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Ras activation

A

Growth factors bind to receptors, relay signal to intracellular GTPases (like Ras), Ras becomes activated by binding GTP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Effect of stimulation of Ras

A

Stimulates phosphorylation cascade (MAP kinase cascade) that leads to activation of nuclear proteins that activate transcription, cell cycle is activated

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Ras activation of the cell cycle

A

Mutations cause Ras to remain in active (GTP-bound) conformation leading to oncogenesis, Ras mutations are found in 20-25% of human tumors and up to 90% of specific tumor types

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Neurofibromin (NF-1)

A

NF-1 activates Ras GTPase, NF-1 is a tumor suppressor, mutations in NF-1 cause neurofibromatosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Retinoblastoma

A

Tumors from embryonic neural retina, occurs in young children, led to isolation of retinoblastoma suppressor gene Rb-1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Retinoblastoma protein (Rb)

A

Tumor suppressor product of the retinoblastoma gene, protein that functions as a negative regulator of cell cycle, arrests cells in G1 phase, halts cell proliferation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Action of retinoblastoma protein (Rb)

A

Binds to transcription factors (E2F1), unphosphorylated during the G0 and G1 phases, multiply phosphorylated during S and G2/M phases

22
Q

Rb and the cell cycle

A

Binds and inactivates E2F (initiates the G1/S cell cycle transition), Rb controls a crucial cell cycle checkpoint- G1/S

23
Q

Key regulators of cell cycle

A

p16/INK4, cyclin D, CDK4, Rb, at least one is dysregulated in vast majority of human cancers

24
Q

p53

A

Transcription factor regulating cell cycle, DNA repair, and programmed cell death, senses DNA damage or hypoxia

25
Q

Actions of p53

A

Upon sensing DNA damage it: halts cell cycle so new DNA synthesis will not replicate damaged DNA, up-regulates genes involved in DNA repair, and stimulates apoptosis if damage is severe

26
Q

p53 mutation

A

Most frequent mutation leading to cancer

27
Q

Li Fraumeni syndrome

A

Genetic defect in p53 leads to a high frequency of cancer in affected individuals

28
Q

p27

A

Inhibits cyclin and Cdk, blocking entry into S phase, used for breast cancer prognosis, reduced levels of p27 predict poor outcome for breast cancer

29
Q

Role of cell adhesion

A

Cadherins bind cells together, anchored by catenins and actin, loss of E-cadherin allows detachment and metastasis, catenins also function as transcription factors

30
Q

CDH1

A

Mutation in E-cadherin- diffuse gastric cancer

31
Q

APC

A

Adenomatous polyposis coli, inhibits beta-catenin, mutations cause sporadic colon cancer, inherited mutations cause familial adenomatous polyposis (FAP)

32
Q

Apoptosis

A

Programmed cell death, cells are no longer needed, executed by caspases

33
Q

Activation of caspases

A

Activated by ligands, such as tumor necrosis factor (TNF) binding the death receptor or by cytochrome c from mitochondria

34
Q

Death receptors

A

Fas/CD95, TNF-receptor 1 (TNF-R1), death receptor 3 (DR3)

35
Q

Death receptor pathway

A

Activated receptor binds two inhibitor caspases (8, 10) which activate each other, they activate execution caspases (3, 6, 7), caspase 3 activates a Bcl-2 family member Bid which affects mitochondrial integrity

36
Q

Activation of caspases

A

Synthesized as inactive precursors called procaspases, once activated they cleave other procaspases to activate them, resulting in amplifying proteolytic cascade

37
Q

Activation of apoptotic procaspases

A

Activated by an apoptosome composed of cytochrome c and Apaf-1 (pro-apoptotic protease activating factor-1)

38
Q

Bcl-2 family proteins

A

Signal integration, 30 homologous proteins with BH domains, 4 BH domains = anti-apoptosis, 3 BH = form channels, 1 BH = pro-apoptosis

39
Q

Philadelphia chromosome

A

Results from translocation between the long arms of chromosome 9 and 22, creates Bcr-Abl fusion protein, Abl is tyrosine kinase (proto-oncogene) and part of signaling cascade, when fused with Bcr it is always active, can lead to chronic myelogenous leukemia (CML)

40
Q

Burkitt’s lymphoma

A

Caused by oncogenic transformation due to translocation, causes c-myc gene to be controlled by the promoter for immunoglobulin heavy chain gene, c-myc is transcription factor, synthesized at high levels induces proliferation of white blood cells

41
Q

N-myc amplification

A

Amplified in neuroblastoma, occurs as double minutes, chromosomally integrated homogenous staining region (HSR)

42
Q

Nonsurgical cancer treatment- target DNA replication

A

Anti-folates, base analogues, alkylating agents, ionizing radiation

43
Q

Anti-folates

A

Target thymidylate synthase, purine synthesis, ex- methotrexate)

44
Q

Base analogues

A

Target thymidylate synthase, ex- 5-Fluorouracil

45
Q

Alkylating agents

A

Damage DNA, triggers apoptosis, ex- cyclophosphamide, cisplatin, cancer cells with inactive p53 proteins can avoid apoptosis

46
Q

Ionizing radiation

A

Damages DNA, triggers apoptosis, cancer cells with inactive p53 proteins can avoid apoptosis

47
Q

Nonsurgical cancer treatment- interfere with mitotic apparatus

A

Microtubule depolymerizing drugs (vinblastine), microtubule polymerizing drugs (taxol), inhibit microtubule function during mitosos of the cell cycle, causing mitotic arrest

48
Q

Nonsurgical cancer treatment- choke off blood supply

A

Drugs that block angiogensis, drugs blocking VEGF (Avastin)

49
Q

Nonsurgical cancer treatment- target oncogenic proteins with inhibitors

A

Monoclonal antibodies (herceptin- blocks Her2 receptor, Her2 overexpressed in breast tumors), active site inhibitors (Gleevec- binds active site of Bcr-abl tyrosine kinase and inactivates it)

50
Q

Important tumor suppressor genes

A

Normally control cell cycle and proliferation, Rb, CDK inhibitors (p21, p27, INK4/p16)

51
Q

Important oncogenes

A

Enhance cell proliferation when activated, Ras, myc, abl

52
Q

Important DNA repair genes

A

Help maintain integrity of genome, BRCA1, BRCA2, mismatch repair genes